Anxiety Disorders

• 

  Subject Areas on Research

  • 12-month prevalence and concomitants of DSM-IV depression and anxiety disorders in two violence-prone cities in Brazil. 
  • 24- and 36-week outcomes for the Child/Adolescent Anxiety Multimodal Study (CAMS). 
  • 49th Annual Meeting of the American Academy of Child & Adolescent Psychiatry. 22-27 October 2002, San Francisco, CA, USA. 
  • 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. 
  • A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder. 
  • A combined treatment approach to anxiety in the medically ill. 
  • A comparison of pure and comorbid CD/ODD and depression. 
  • A construct validity study of the Missouri Children's Behavior Checklist with developmentally disabled children. 
  • A diagnostic and family study of posttraumatic stress disorder. 
  • A family study of chronic post-traumatic stress disorder following rape trauma. 
  • A longitudinal study of neurosis in young men. 
  • A pilot study of amygdala volumes in pediatric generalized anxiety disorder. 
  • A placebo-controlled study of Kava kava in generalized anxiety disorder. 
  • A probabilistic and individualized approach for predicting treatment gains: an extension and application to anxiety disordered youth. 
  • A psychopharmacological treatment algorithm for generalised anxiety disorder (GAD). 
  • A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia. 
  • A randomized trial of the effect of prayer on depression and anxiety. 
  • A study of depressive typologies using grade of membership analysis. 
  • ACP Journal Club: review: in primary care, screening with the GAD-7 detected anxiety disorder; the PHQ detected panic disorder. 
  • ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. 
  • Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms. 
  • Adult Associations of Childhood Suicidal Thoughts and Behaviors: A Prospective, Longitudinal Analysis. 
  • Adult Functional Outcomes of Common Childhood Psychiatric Problems: A Prospective, Longitudinal Study. 
  • Adverse behavioral and emotional outcomes from child abuse and witnessed violence. 
  • Age differences in symptom expression in patients with major depression. 
  • Alpha 2 adrenergic agonists. Neurochemistry, efficacy, and clinical guidelines for use in children. 
  • An abbreviated version of the Connor-Davidson Resilience Scale (CD-RISC), the CD-RISC2: psychometric properties and applications in psychopharmacological trials. 
  • An appraisal of cognitive therapy. 
  • An assessment of the Newcastle Anxiety Depression Index. 
  • An effect-size analysis of pharmacologic treatments for generalized anxiety disorder. 
  • An evaluation of the measurement of pain catastrophizing by the coping strategies questionnaire. 
  • An evidence-based medicine approach to combined treatment for ADHD in children and adolescents. 
  • Antidepressant Regulatory Warnings, Prescription Patterns, Suicidality and Other Aggressive Behaviors in Major Depressive Disorder and Anxiety Disorders. 
  • Antidepressant medication use in palliative care. 
  • Anxiety Associated Increased CpG Methylation in the Promoter of Asb1: A Translational Approach Evidenced by Epidemiological and Clinical Studies and a Murine Model. 
  • Anxiety Disorders in Caucasian and African American Children: A Comparison of Clinical Characteristics, Treatment Process Variables, and Treatment Outcomes. 
  • Anxiety Disorders in Late Life. 
  • Anxiety and cerebral blood flow. 
  • Anxiety and depression in a primary care clinic. Comparison of Diagnostic Interview Schedule, General Health Questionnaire, and practitioner assessments. 
  • Anxiety and depressive disorders and the five-factor model of personality: a higher- and lower-order personality trait investigation in a community sample. 
  • Anxiety and depressive symptom identification using the Duke Health Profile. 
  • Anxiety in medically ill older patients: a review and update. 
  • Anxiety in middle adulthood: effects of age and time on the 14-year course of panic disorder, social phobia and generalized anxiety disorder. 
  • Anxiety in youth with and without autism spectrum disorder: examination of factorial equivalence. 
  • Anxiety sensitivity as a predictor of the clinical course of panic disorder: a 1-year follow-up study. 
  • Anxiety symptoms and functional impairment: A systematic review of the correlation between the two measures. 
  • Anxiety symptoms bias memory assessment in older adults. 
  • Anxiety-like behaviors in mice lacking GIT2. 
  • Applications of TMS to therapy in psychiatry. 
  • Assessing anxiety in youth with the multidimensional anxiety scale for children. 
  • Assessing the Relationship between Anxiety and Revision Surgery following Autologous Breast Reconstruction. 
  • Association of anxiety and depression with all-cause mortality in individuals with coronary heart disease. 
  • Association of anxiety and depression with pulmonary-specific symptoms in chronic obstructive pulmonary disease. 
  • Association of comorbid generalized anxiety disorder and alcohol use disorder symptoms with health-related quality of life: results from the National Epidemiological Survey on Alcohol and Related Conditions. 
  • Association of somatic symptoms with depression and anxiety in clinical patients of general hospitals in Guangzhou, China. 
  • Associations between Anxiety, Poor Prognosis, and Accurate Understanding of Scan Results among Advanced Cancer Patients. 
  • Associations between temperament and DSM-IV externalizing disorders in children and adolescents. 
  • Associations of parental personality disorders and axis I disorders with childrearing behavior. 
  • Attention bias toward threat in pediatric anxiety disorders. 
  • Autobiographical memories of anxiety-related experiences. 
  • Behavioral and cerebrovascular effects of caffeine in patients with anxiety disorders. 
  • Behavioural equivalents of anxiety in children with fragile X syndrome: parent and teacher report. 
  • Belief in life after death and mental health: findings from a national survey. 
  • Benefits of child-focused anxiety treatments for parents and family functioning. 
  • Botanical medicines for anxiety: do they have a place? 
  • CBT versus supportive therapy for depression. 
  • Cerebellar volumes in pediatric maltreatment-related posttraumatic stress disorder. 
  • Cerebral blood flow changes induced by CO2 in anxiety. 
  • Cerebral blood flow responses to CO2 and acetazolamide: the effect of anxiety. 
  • Cerebral vasodilation and vasoconstriction associated with acute anxiety. 
  • Challenging assumptions from emotion dysregulation psychological treatments. 
  • Change is not always linear: the study of nonlinear and discontinuous patterns of change in psychotherapy. 
  • Changes in Problematic Anger, Shame, and Disgust in Anxious and Depressed Adults Undergoing Treatment for Emotion Dysregulation. 
  • Changes in neuroticism following trauma exposure. 
  • Characteristics associated with presence of depressive symptoms in adults with autism spectrum disorder. 
  • Child and Adolescent Adherence With Cognitive Behavioral Therapy for Anxiety: Predictors and Associations With Outcomes. 
  • Childhood IQ and adult mental disorders: a test of the cognitive reserve hypothesis. 
  • Childhood and adolescent psychiatric disorders as predictors of young adult disorders. 
  • Childhood anxiety: lessons learned. 
  • Childhood behavioral and emotional disorders. 
  • Childhood maltreatment, juvenile disorders and adult post-traumatic stress disorder: a prospective investigation. 
  • Childhood somatic complaints predict generalized anxiety and depressive disorders during young adulthood in a community sample. 
  • Chronic pain and depression. II. Symptoms of anxiety in chronic low back pain patients and their relationship to subtypes of depression. 
  • Classification of trauma and stressor-related disorders in DSM-5. 
  • Clinical characteristics of anxiety disordered youth. 
  • Clinical correlates of anxious depression among elderly patients with depression. 
  • Clinical experience with substance P receptor (NK1) antagonists in depression. 
  • Clinical outcomes of older depressed patients with and without comorbid neuroticism. 
  • Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS). 
  • Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. 
  • Cognitive-Behavioral Therapy for College Students With ADHD: Temporal Stability of Improvements in Functioning Following Active Treatment. 
  • Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review. 
  • Cognitive-behavioral therapy for youth anxiety: An effectiveness evaluation in community practice. 
  • Common and distinct neural features of social and non-social reward processing in autism and social anxiety disorder. 
  • Common emotional and behavioral disorders in preschool children: presentation, nosology, and epidemiology. 
  • Comorbid Anxiety and Depressive Symptoms in Children and Adolescents: A Systematic Review and Analysis. 
  • Comorbid depression and anxiety effects on pregnancy and neonatal outcome. 
  • Comorbid substance and mental disorders among rural Americans: results from the National Comorbidity Survey. 
  • Comorbidity and depression treatment. 
  • Comorbidity. 
  • Comparison of men and women with binge eating disorder 
  • Completeness of response and quality of life in mood and anxiety disorders. 
  • Concordance of genetic variation that increases risk for anxiety disorders and posttraumatic stress disorders and that influences their underlying neurocircuitry. 
  • Consensus statement on depression, anxiety, and cardiovascular disease. 
  • Consensus statement on depression, anxiety, and functional gastrointestinal disorders. 
  • Consensus statement on depression, anxiety, and oncology. 
  • Consensus statement on generalized anxiety disorder from the International Consensus Group on Depression and Anxiety. 
  • Consensus statement on social anxiety disorder from the International Consensus Group on Depression and Anxiety. 
  • Consensus statement on transcultural issues in depression and anxiety from the International Consensus Group on Depression and Anxiety. 
  • Consumers who call the Anxiety Disorders Association of America: characteristics and satisfaction. 
  • Contemporary management of comorbid anxiety and depression in geriatric patients. 
  • Continuation treatment of panic disorder with high-potency benzodiazepines. 
  • Convergent effects of mouse Pet-1 deletion and human PET-1 variation on amygdala fear and threat processing. 
  • Cultural concepts of distress and psychiatric disorders: literature review and research recommendations for global mental health epidemiology. 
  • Daily left prefrontal repetitive transcranial magnetic stimulation in the acute treatment of major depression: clinical predictors of outcome in a multisite, randomized controlled clinical trial. 
  • Deficient behavioral inhibition and anomalous selective attention in a community sample of adolescents with psychopathic traits and low-anxiety traits. 
  • Defining Treatment Response and Remission in Youth Anxiety: A Signal Detection Analysis With the Multidimensional Anxiety Scale for Children. 
  • Defining treatment response and remission in child anxiety: signal detection analysis using the pediatric anxiety rating scale. 
  • Demographics, treatment seeking, and diagnoses of anxiety support group participants. 
  • Depressed adolescents and comorbid psychiatric disorders: are there differences in the presentation of depression? 
  • Depression and Anxiety Disorders among Hospitalized Women with Breast Cancer. 
  • Depression and anxiety among pregnant women living with HIV in Kilimanjaro region, Tanzania. 
  • Depression and anxiety disorder among older male inmates at a federal correctional facility. 
  • Depression and generalized anxiety disorder: cumulative and sequential comorbidity in a birth cohort followed prospectively to age 32 years. 
  • Depression in male and female patients undergoing cardiac surgery. 
  • Depression in patients with colorectal cancer in Saudi Arabia. 
  • Depression in persons with diabetes by age and antidiabetic treatment: a cross-sectional analysis with data from the Hordaland Health Study. 
  • Depressive comorbidity in children and adolescents: empirical, theoretical, and methodological issues. 
  • Depressive comorbidity in preschool anxiety disorder. 
  • Depressive symptoms and depressive diagnoses in a community population. Use of a new procedure for analysis of psychiatric classification. 
  • Designing a pilot sequential multiple assignment randomized trial for developing an adaptive treatment strategy. 
  • Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC). 
  • Diagnostic specificity and nonspecificity in the dimensions of preschool psychopathology. 
  • Diagnostic transitions from childhood to adolescence to early adulthood. 
  • Differential diagnosis and pathophysiology of Cushing's syndrome and primary affective disorder. 
  • Dimensions of social support and depression in patients at increased psychosocial risk recovering from myocardial infarction. 
  • Distress persists in long-term brain tumor survivors with glioblastoma multiforme. 
  • Do benzodiazepines have a role in the prevention or treatment of coronary heart disease and other major medical disorders? 
  • Do dehydroepiandrosterone, progesterone, and testosterone influence women's depression and anxiety levels? Evidence from hair-based hormonal measures of 2105 rural Indian women. 
  • Does a coexisting anxiety disorder predict persistence of depressive illness in primary care patients with major depression? 
  • Does this patient have generalized anxiety or panic disorder?: The Rational Clinical Examination systematic review. 
  • Duloxetine treatment for relapse prevention in adults with generalized anxiety disorder: a double-blind placebo-controlled trial. 
  • Dysregulation of DGCR6 and DGCR6L: psychopathological outcomes in chromosome 22q11.2 deletion syndrome. 
  • Early and late side effects of phenelzine. 
  • Editorial: measuring hypervigilance and anxiety in oesophageal disorders. 
  • Effects of HTR1A C(-1019)G on amygdala reactivity and trait anxiety. 
  • Effects of aerobic exercise on cognitive and psychosocial functioning in patients with mild hypertension. 
  • Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials. 
  • Efficacy and tolerability of antidepressants in pediatric anxiety disorders: a systematic review and meta-analysis. 
  • Efficacy and tolerability of duloxetine in elderly patients with generalized anxiety disorder: a pooled analysis of four randomized, double-blind, placebo-controlled studies. 
  • Efficacy, safety, and tolerability of venlafaxine extended release and buspirone in outpatients with generalized anxiety disorder. 
  • Emotional reactions to pain predict psychological distress in adult patients with Sickle Cell Disease (SCD). 
  • Epidemiology of late-life mental disorders. 
  • Escitalopram in the treatment of generalized anxiety disorder: double-blind, placebo controlled, flexible-dose study. 
  • Establishing the neurobiologic basis of treatment in children and adolescents with generalized anxiety disorder. 
  • Eszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder. 
  • Evaluation of a classroom-based psychosocial intervention in conflict-affected Nepal: a cluster randomized controlled trial. 
  • Evaluation of agreement between physicians' notation of 'no evidence of disease' (NED) and patients' report of cancer status. 
  • Evaluation of the effects of diazepam and an experimental anti-anxiety drug on regional cerebral blood flow. 
  • Evidence Map of Yoga for Depression, Anxiety, and Posttraumatic Stress Disorder. 
  • Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology. 
  • Examining Parental Medication Adherence as a Predictor of Child Medication Adherence in Pediatric Anxiety Disorders. 
  • Exercise as Treatment for Anxiety: Systematic Review and Analysis. 
  • Explained and unexplained medical symptoms in generalized anxiety and panic disorder: relationship to the somatoform disorders. 
  • Explanatory attributions of anxiety and recovery in a study of kava. 
  • Extended Release Guanfacine in Pediatric Anxiety Disorders: A Pilot, Randomized, Placebo-Controlled Trial. 
  • Extracellular-signal regulated kinase 1-dependent metabotropic glutamate receptor 5-induced long-term depression in the bed nucleus of the stria terminalis is disrupted by cocaine administration. 
  • Failure of glucagon-like peptide-1 to induce panic attacks or anxiety in patients with panic disorder. 
  • Familial psychiatric illness in chronic posttraumatic stress disorder. 
  • Family environment as a moderator of the association between anxiety and suicidal ideation. 
  • Family history of depression and therapeutic outcome: findings from STAR*D. 
  • Fear and anxiety from principle to practice: implications for when to treat youth with anxiety disorders. 
  • Fear, avoidance and physiological symptoms during cognitive-behavioral therapy for social anxiety disorder. 
  • First-line pharmacotherapy approaches for generalized anxiety disorder. 
  • First-time suicide attempters, repeat attempters, and previous attempters on an adolescent inpatient psychiatry unit. 
  • Fluvoxamine for the treatment of anxiety disorders in children and adolescents. The Research Unit on Pediatric Psychopharmacology Anxiety Study Group. 
  • Forms of atypical depression and their response to antidepressant drugs. 
  • Gender role orientation and fearfulness in children with anxiety disorders. 
  • Generalized anxiety and C-reactive protein levels: a prospective, longitudinal analysis. 
  • Generalized anxiety disorder and depression: childhood risk factors in a birth cohort followed to age 32. 
  • Generalized anxiety disorder and panic disorder in the elderly: a review. 
  • Generalized anxiety disorder. An important clinical concern. 
  • Generalized anxiety disorder: acute and chronic treatment. 
  • Generalized anxiety disorder: nature and course. 
  • Generalized anxiety disorder: neurobiological and pharmacotherapeutic perspectives. 
  • Genetic variation in human NPY expression affects stress response and emotion. 
  • Harmonization of Neuroticism and Extraversion phenotypes across inventories and cohorts in the Genetics of Personality Consortium: an application of Item Response Theory. 
  • Hazardous drinking and clinical correlates among suicidal patients receiving psychiatric inpatient care at military medical settings. 
  • Heritability and reliability of automatically segmented human hippocampal formation subregions. 
  • History of depressive and/or anxiety disorders as a predictor of treatment response: a post hoc analysis of a 12-week, randomized, double-blind, placebo-controlled trial of paroxetine controlled release in patients with fibromyalgia. 
  • How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. 
  • How do prescription opioid users differ from users of heroin or other drugs in psychopathology: results from the National Epidemiologic Survey on Alcohol and Related Conditions. 
  • Hypothalamic-pituitary-adrenal axis genetic variation and early stress moderates amygdala function. 
  • Identity disturbance and problems with emotion regulation are related constructs across diagnoses. 
  • Immediate therapist self-disclosure bolsters the effect of brief integrative psychotherapy on psychiatric symptoms and the perceptions of therapists: A randomized clinical trial. 
  • Impact of depression and anxiety on the quality of life of constipated patients. 
  • Impact of depressive symptoms on the treatment of generalized social anxiety disorder. 
  • Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS). 
  • Impact of symptoms of generalized anxiety disorder on the course of late-life depression. 
  • In-home mental health treatment for individuals with HIV. 
  • Incidence of mental health hospitalizations, treated self-harm, and emergency room visits following new anxiety disorder diagnoses in privately insured U.S. children. 
  • Incident Substance Use Disorder Following Anxiety Disorder in Privately Insured Youth. 
  • Increased postwar symptoms and psychological morbidity among U.S. Navy Gulf War veterans. 
  • Indicators of anxiety and depression in women with the fragile X premutation: assessment of a clinical sample. 
  • Individuals with autism spectrum disorder show normal responses to a fear potential startle paradigm. 
  • Insomnia in women. 
  • Interactions of peptide amidation and copper: novel biomarkers and mechanisms of neural dysfunction. 
  • Interactive effect of substance abuse and depression on adolescent social competence. 
  • Internal consistency of DSM-III diagnoses using the symptom scales of the Child Assessment Schedule. 
  • Internalizing disorders and leukocyte telomere erosion: a prospective study of depression, generalized anxiety disorder and post-traumatic stress disorder. 
  • Intracranial and extracranial blood flow during acute anxiety. 
  • Juvenile mental health histories of adults with anxiety disorders. 
  • Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials. 
  • Kava in generalized anxiety disorder: three placebo-controlled trials. 
  • Lifetime major depression and comorbid disorders among current-era women veterans. 
  • Links between anxiety and allergies: psychobiological reality or possible methodological bias? 
  • Long-term outcomes for the Child STEPs randomized effectiveness trial: a comparison of modular and standard treatment designs with usual care. 
  • Longitudinal course of anxiety sensitivity and PTSD symptoms in cognitive-behavioral therapies for PTSD. 
  • Longitudinal patterns of anxiety from childhood to adulthood: the Great Smoky Mountains Study. 
  • MAO inhibition and control of anxiety following amitriptyline therapy. A pilot study. 
  • MAO inhibitor therapy in trichotillomania associated with depression: case report. 
  • Major depression, generalized anxiety disorder, and panic disorder in patients scheduled for knee arthroplasty. 
  • Making sense of informant disagreement for overanxious disorder. 
  • Management of late-life depression: focus on comorbid conditions. 
  • Massage reduces anxiety in child and adolescent psychiatric patients. 
  • Mediators of Treatment Outcomes for Anxious Children and Adolescents: The Role of Somatic Symptoms. 
  • Mediators of change in the Child/Adolescent Anxiety Multimodal Treatment Study. 
  • Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder. 
  • Methodology and preliminary results from the neurobiology of late-life depression study. 
  • Mind-Body Approaches to Treating Mental Health Symptoms Among Disadvantaged Populations: A Comprehensive Review. 
  • Mood and suicidality outcomes 3-11 years following pediatric anxiety disorder treatment. 
  • Morbidity of DSM-IV Axis I disorders in patients with noncardiac chest pain: Psychiatric morbidity linked with increased pain and health care utilization. 
  • Mother-child agreement on the child assessment schedule with nonreferred children: a research note. 
  • Multi-informant Expectancies and Treatment Outcomes for Anxiety in Youth. 
  • Naturalistic follow-up of youths treated for pediatric anxiety disorders. 
  • Neurobiological mechanisms in generalized anxiety disorder. 
  • Neuropsychological assessment of response inhibition in adults with ADHD. 
  • Neuropsychological correlates of psychopathology in an unselected cohort of young adolescents. 
  • Nosology and measurement in child and adolescent psychiatry. 
  • Observed classroom behavior of children with ADHD: relationship to gender and comorbidity. 
  • Obsessions and compulsions in the community: prevalence, interference, help-seeking, developmental stability, and co-occurring psychiatric conditions. 
  • Obsessive-compulsive disorder in callers to the Anxiety Disorders Association of America. 
  • Off-label applications for SSRIs. 
  • Off-label uses for selective serotonin reuptake inhibitors. 
  • Open-label pilot study of ziprasidone for refractory generalized anxiety disorder. 
  • Organic anxiety disorder. Iatrogenic hyperthyroidism. 
  • PDI-4A: an augmented provisional screening instrument assessing 5 additional common anxiety-related diagnoses in adult primary care patients. 
  • PTSD diagnoses, subsyndromal symptoms, and comorbidities contribute to impairments for breast cancer survivors. 
  • Parent-reported homework problems in the MTA study: evidence for sustained improvement with behavioral treatment. 
  • Parental anxiety as a predictor of medication and CBT response for anxious youth. 
  • Paroxetine in the treatment of generalised anxiety disorder. 
  • Pathways from anxiety to stressful events: An expansion of the stress generation hypothesis. 
  • Pathways to PTSD, part II: Sexually abused children. 
  • Patient compliance with MAO inhibitor therapy. 
  • Perceived family impact of preschool anxiety disorders. 
  • Perceived mental health and disablement of primary care and end-stage renal disease patients. 
  • Perceived stress and everyday memory complaints among older adult women. 
  • Perception of cognitive function in older adults following coronary artery bypass surgery. 
  • Person-Centered Profiles Among Treatment-Seeking Children and Adolescents with Anxiety Disorders. 
  • Personality Structure Among Centenarians: The Georgia Centenarian Study. 
  • Personality and cognitive decline in the Baltimore Epidemiologic Catchment Area follow-up study. 
  • Pharmacologic treatment of acute and chronic stress following trauma: 2006. 
  • Pharmacotherapy for anxiety disorders in children and adolescents: an evidence-based medicine review. 
  • Pharmacotherapy of generalized anxiety disorder. 
  • Pharmacotherapy of impaired affect in recovering schizophrenic patients. 
  • Phase 2 pilot study of Pathfinders: a psychosocial intervention for cancer patients. 
  • Physician office visits of adults for anxiety disorders in the United States, 1985-1998. 
  • Placebo Response in Pediatric Anxiety Disorders: Results from the Child/Adolescent Anxiety Multimodal Study. 
  • Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. 
  • Positron emission tomography in neuropsychiatry. 
  • Posttraumatic stress disorder in callers to the Anxiety Disorders Association of America. 
  • Posttraumatic stress disorder: anxiety or traumatic stress disorder? 
  • Practice patterns in the diagnosis and treatment of anxiety and depression in the medically ill. A survey of psychiatrists. 
  • Predicting Persistent, Limited, and Delayed Problematic Cannabis Use in Early Adulthood: Findings From a Longitudinal Study. 
  • Predicting response to amitriptyline in posttraumatic stress disorder. 
  • Predicting the outcome of treatment. 
  • Predictive value of family history on severity of illness: the case for depression, anxiety, alcohol dependence, and drug dependence. 
  • Predictors and moderators of treatment response in childhood anxiety disorders: results from the CAMS trial. 
  • Predictors of depression recovery in HIV-infected individuals managed through measurement-based care in infectious disease clinics. 
  • Pregabalin in generalized anxiety disorder: a placebo-controlled trial. 
  • Preschool anxiety disorders in pediatric primary care: prevalence and comorbidity. 
  • Preschool psychopathology: lessons for the lifespan. 
  • Prevalence and comorbidity of psychiatric diagnoses based on reference standard in an HIV+ patient population. 
  • Prevalence of anxiety disorders in men and women with established coronary heart disease. 
  • Prevalence of psychiatric disorders in preschoolers. 
  • Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey. 
  • Primary care physicians' and psychiatrists' willingness to refer to religious mental health providers. 
  • Prior juvenile diagnoses in adults with mental disorder: developmental follow-back of a prospective-longitudinal cohort. 
  • Prospective longitudinal associations between persistent sleep problems in childhood and anxiety and depression disorders in adulthood. 
  • Proximal psychiatric risk factors for suicidality in youth: the Great Smoky Mountains Study. 
  • Psychiatric Comorbidity of Unipolar Mood, Anxiety, and Trauma Disorders Prior to HIV Testing and the Effect on Linkage to Care Among HIV-Infected Adults in South Africa. 
  • Psychiatric and medical comorbidities of bipolar disorder. 
  • Psychiatric comorbidity in depressed HIV-infected individuals: common and clinically consequential. 
  • Psychiatric disorder and quality of life in patients awaiting lung transplantation. 
  • Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. 
  • Psychiatric disorders in adult children of alcoholics: data from the Epidemiologic Catchment Area project. 
  • Psychiatric disorders in inhalant users: results from The National Epidemiologic Survey on Alcohol and Related Conditions. 
  • Psychiatric disorders in medical outpatients complaining of palpitations. 
  • Psychiatric disorders in youths with IDDM: rates and risk factors. 
  • Psychiatric illness and virologic response in patients initiating highly active antiretroviral therapy. 
  • Psychiatric syncope: a new look at an old disease. 
  • Psychometric properties of the UCLA PTSD reaction index: part I. 
  • Psychopharmacologic treatment of children and adolescents with anxiety disorders. 
  • Psychotherapy Claims Surrounding Pharmacotherapy Initiation in Children and Adolescents with Anxiety Disorders. 
  • Psychotherapy Targeting Depression and Anxiety for Use in Palliative Care: A Meta-Analysis. 
  • Psychotic disorders cause the greatest mortality disparity among mental disorders, though more deaths are attributable overall to mood and anxiety disorders. 
  • Quality of life for adult leukemia survivors treated on clinical trials of Cancer and Leukemia Group B during the period 1971-1988: predictors for later psychologic distress. 
  • Quantifying Risk for Anxiety Disorders in Preschool Children: A Machine Learning Approach. 
  • Quetiapine as monotherapy for social anxiety disorder: a placebo-controlled study. 
  • Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings. 
  • Reading problems, psychiatric disorders, and functional impairment from mid- to late adolescence. 
  • Recent advances in the understanding and treatment of anxiety disorders. Resilience: determinants, measurement, and treatment responsiveness. 
  • Reconsidering somatic presentation of generalized anxiety disorder in Nepal. 
  • Refining criteria for posttraumatic stress disorder. 
  • Relational aggression in children with preschool-onset psychiatric disorders. 
  • Relationship between abdominal pain subgroups in the community and psychiatric diagnosis and personality. A birth cohort study. 
  • Relationships between body satisfaction and psychological functioning and weight-related cognitions and behaviors in overweight adolescents. 
  • Relative abundance of Akkermansia spp. and other bacterial phylotypes correlates with anxiety- and depressive-like behavior following social defeat in mice. 
  • Religion and anxiety treatments in primary care patients. 
  • Remission after acute treatment in children and adolescents with anxiety disorders: findings from the CAMS. 
  • Remission of generalized anxiety disorder after 6 months of open-label treatment with venlafaxine XR. 
  • Repairing the shattered self: recovering from trauma. 
  • Research on religion, spirituality, and mental health: a review. 
  • Responses to hypercarbia induced by acetazolamide in panic disorder patients. 
  • Results From the Child/Adolescent Anxiety Multimodal Extended Long-Term Study (CAMELS): Primary Anxiety Outcomes. 
  • Results from the Child/Adolescent Anxiety Multimodal Longitudinal Study (CAMELS): Functional outcomes. 
  • Safety and efficacy of escitalopram in the long-term treatment of generalized anxiety disorder. 
  • Schedule for affective disorders and schizophrenia for school-age children (K-SADS-PL) for the assessment of preschool children--a preliminary psychometric study. 
  • Screening for anxiety and depression in primary care with the Duke Anxiety-Depression Scale. 
  • Screening for distress in patients with brain cancer using the NCCN's rapid screening measure. 
  • Screening parents during child evaluations: exploring parent and child psychopathology in the same clinic. 
  • Selective Serotonin Reuptake Inhibitors and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation: An Analysis From the ROCKET AF Trial. 
  • Self-efficacy for managing pain, symptoms, and function in patients with lung cancer and their informal caregivers: associations with symptoms and distress. 
  • Sensory Over-Responsivity: An Early Risk Factor for Anxiety and Behavioral Challenges in Young Children. 
  • Serotonergic genotypes, neuroticism, and financial choices. 
  • Serotonin transporter (5-HTTLPR) genotype and amygdala activation: a meta-analysis. 
  • Sertraline in children and adolescents with social anxiety disorder: an open trial. 
  • Severity of emotional and behavioral problems among poor and typical readers. 
  • Sex differences in response to chronic mild stress and congenital serotonin deficiency. 
  • Sex differences in the associations among psychological factors and pain report: a novel psychophysical study of patients with chronic low back pain. 
  • Short stature, growth hormone deficiency, and social anxiety. 
  • Sleep problems in childhood predict neuropsychological functioning in adolescence. 
  • Sleep problems predict and are predicted by generalized anxiety/depression and oppositional defiant disorder. 
  • Sleep-Related Problems and the Effects of Anxiety Treatment in Children and Adolescents. 
  • Social anxiety disorder in callers to the Anxiety Disorders Association of America. 
  • Social anxiety disorder under scrutiny. 
  • Social skills and associated psychopathology in children with chromosome 22q11.2 deletion syndrome: implications for interventions. 
  • Somatic complaints in anxious youth. 
  • Spousal depression, anxiety, and suicide after myocardial infarction. 
  • St. John's wort in generalized anxiety disorder: three case reports. 
  • Stimulus-Driven Attention, Threat Bias, and Sad Bias in Youth with a History of an Anxiety Disorder or Depression. 
  • Stressful life events and the onset of a generalized anxiety syndrome. 
  • Substance use and mental diagnoses among adults with and without type 2 diabetes: Results from electronic health records data. 
  • Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study. 
  • Suicidality as a possible side effect of antidepressant treatment. 
  • Superior temporal gyrus volumes in pediatric generalized anxiety disorder. 
  • Symptom and comorbidity patterns in World War II and Vietnam veterans with posttraumatic stress disorder. 
  • Symptom profiles in children with ADHD: effects of comorbidity and gender. 
  • Telomere length is associated with sleep duration but not sleep quality in adults with human immunodeficiency virus. 
  • Test of mindfulness and hope components in a psychological intervention for women with cancer recurrence. 
  • The Effect of Holy Qur'an Recitation on Anxiety in Hemodialysis Patients: A Randomized Clinical Trial. 
  • The Effects of Youth Anxiety Treatment on School Impairment: Differential Outcomes Across CBT, Sertraline, and their Combination. 
  • The Interaction Anxiousness Scale: construct and criterion-related validity. 
  • The Interplay of Familial and Individual Risk in Predicting Clinical Improvements in Pediatric Anxiety Disorders. 
  • The Newcastle Anxiety Depression Diagnostic Index in relationship to the effects of monoamine oxidase inhibitors and tricyclic antidepressants. 
  • The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties. 
  • The anxiety disorders. 
  • The chronically mentally ill in primary care. 
  • The critical warzone experiences (CWE) scale: initial psychometric properties and association with PTSD, anxiety, and depression. 
  • The development and assessment of the Worry About Pain Questionnaire. 
  • The developmental course of illicit substance use from age 12 to 22: links with depressive, anxiety, and behavior disorders at age 18. 
  • The developmental epidemiology of anxiety disorders: phenomenology, prevalence, and comorbidity. 
  • The dysfunctional attitudes scale: psychometric properties in depressed adolescents. 
  • The economic burden of anxiety disorders in the 1990s. 
  • The effect of neuroticism on the recall of persistent low-back pain and perceived activity interference. 
  • The effect of prayer on depression and anxiety: maintenance of positive influence one year after prayer intervention. 
  • The effect of social anxiety on urge and craving among smokers with and without anxiety disorders. 
  • The effects of childhood parental death and divorce on six-month history of anxiety disorders. 
  • The global coverage of prevalence data for mental disorders in children and adolescents. 
  • The impact of anxiety-inducing distraction on cognitive performance: a combined brain imaging and personality investigation. 
  • The impact of psychologic factors on measurement of functional status. Assessment of the sickness impact profile. 
  • The importance of dose in isocarboxazid therapy. 
  • The novel, selective, brain-penetrant neuropeptide Y Y2 receptor antagonist, JNJ-31020028, tested in animal models of alcohol consumption, relapse, and anxiety. 
  • The psychological impact of diabetes: a practical guide for the nurse practitioner. 
  • The psychometric properties of the MASC in a pediatric psychiatric sample. 
  • The relation between insecure attachment and posttraumatic stress: Early life versus adulthood traumas. 
  • The relationship of mental and behavioral disorders to all-cause mortality in a 27-year follow-up of 4 epidemiologic catchment area samples. 
  • The role of nuclear magnetic resonance imaging in psychiatric research. 
  • The therapeutic relationship in cognitive-behavioral therapy and pharmacotherapy for anxious youth. 
  • The use of flumazenil in the anxious and benzodiazepine-dependent ECT patient. 
  • Therapist-Reported Features of Exposure Tasks That Predict Differential Treatment Outcomes for Youth With Anxiety. 
  • Time to relapse after 6 and 12 months' treatment of generalized anxiety disorder with venlafaxine extended release. 
  • Tinnitus Self-Efficacy and Other Tinnitus Self-Report Variables in Patients With and Without Post-Traumatic Stress Disorder. 
  • Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. 
  • Trajectories of change in youth anxiety during cognitive-behavior therapy. 
  • Trauma and posttraumatic stress in users of the Anxiety Disorders Association of America Web site. 
  • Trauma, anxiety and reported health among HIV-positive persons in Tanzania and the US Deep South. 
  • Trauma, comorbidity, and mortality following diagnoses of severe stress and adjustment disorders: a nationwide cohort study. 
  • Trauma, mental health, distrust, and stigma among HIV-positive persons: implications for effective care. 
  • Traumatic events and posttraumatic stress in childhood. 
  • Treating Pediatric Anxiety: Initial Use of SSRIs and Other Antianxiety Prescription Medications. 
  • Treatment of Anxiety in Patients With Coronary Heart Disease: A Systematic Review. 
  • Treatment of posttraumatic stress disorder with amitriptyline and placebo. 
  • Treatment of social anxiety disorder with citalopram. 
  • Uncertainty management intervention for older African American and caucasian long-term breast cancer survivors. 
  • Urinary catecholamine excretion in childhood overanxious and posttraumatic stress disorders. 
  • Use of an electronic patient-reported outcome measurement system to improve distress management in oncology. 
  • Use of benzodiazepines in social anxiety disorder, generalized anxiety disorder, and posttraumatic stress disorder. 
  • Variants of the serotonin transporter gene and NEO-PI-R Neuroticism: No association in the BLSA and SardiNIA samples. 
  • Vida Calma: CBT for Anxiety with a Spanish-Speaking Hispanic Adult. 
  • What are the causes of late-life depression? 
  • What do childhood anxiety disorders predict? 
  • What is generalized anxiety disorder? 
  • When Something is Better Than Nothing: Response to Tully and Cosh. 
  • Which domains of spirituality are associated with anxiety and depression in patients with advanced illness? 
  • Who are the new users of antipsychotic medications? 
  • Why do people with an anxiety disorder utilize more nonmental health care than those without? 
  • Work stress precipitates depression and anxiety in young, working women and men. 
• 

  Keywords of People

  • Brancu, Mira, Associate Professor in Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Social and Community Psychiatry
  • Dodge, Kenneth A., William McDougall Distinguished Professor of Public Policy Studies, Duke Science & Society
  • Humphreys, Janice Carrol, Professor in the School of Nursing, with tenure, School of Nursing
  • Kimbrel, Nathan Andrew, Associate Professor in Psychiatry and Behavioral Sciences, Psychiatry & Behavioral Sciences, Behavioral Medicine
  • O'Connor, Christopher Michael, Richard Sean Stack, M.D. Distinguished Professor, Medicine, Clinical Pharmacology
  • Sullivan, Daniel Carl, Professor Emeritus of Radiology, Radiology
  • Wu, Li-Tzy, Professor in Psychiatry and Behavioral Sciences, Medicine, General Internal Medicine